ALLE vs LYRA · P/E 21, rev $2.19B vs rev $1.5M
Allegion PLC (ALLE) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the ALLE and LYRA stock pages for the full models.
Not investment advice.